News
Stifel Downgrades Gracell Biotechnologies to Hold, Lowers Price Target to $10.25
22 Feb 24
News, Downgrades, Price Target, Analyst Ratings
Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment
23 Jan 24
Biotech, Large Cap, News, Health Care, FDA, General